Excepgen

ExcepGen is a biotechnology company focused on engineering RNA-based therapeutics that aim to improve human health by addressing cellular regulation. The company is dedicated to developing RNA-based vaccines that offer tolerability levels comparable to standard care by mitigating excessive innate immune responses. This innovative approach seeks to enhance the safety and effectiveness of nucleic acid vaccines, which have seen significant advances in recent years due to improvements in capping, delivery, and manufacturing techniques. However, these advancements primarily concentrated on the chem…